Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Vermeire

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Molecular & Cellular Proteomics : MCP|September 5, 2021
A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor CyclotriazadisulfonamideEva Pauwels, Claudia Rutz, Becky Provinciael, et al.
Molecular Pharmacology|December 19, 2002
The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptorKurt Vermeire, Thomas W Bell, Heung-Jin Choi, et al.
Bioorganic & Medicinal Chemistry|November 12, 2020
Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compoundsLiezel A Lumangtad, Elisa Claeys, Sunil Hamal, et al.
Arthritis Research & Therapy|November 10, 2005
Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritisBert De Klerck, Lies Geboes, Sigrid Hatse, et al.
Microbiology Resource Announcements|May 18, 2019
Complete Genome Sequence of a New Ebola Virus Strain Isolated during the 2017 Likati Outbreak in the Democratic Republic of the CongoTony Wawina-Bokalanga, Bert Vanmechelen, Joan Martí-Carreras, et al.
European Journal of Medicinal Chemistry|January 30, 2025
The chiral 5,6-cyclohexane-fused uracil ring-system: A molecular platform with promising activity against SARS-CoV-2Enrico Marcantonio, Debora Guazzetti, Crescenzo Coppa, et al.
FEBS Letters|July 2, 2003
Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entrySigrid Hatse, Katrien Princen, Kurt Vermeire, et al.
Journal of Virology|January 26, 2007
Modest human immunodeficiency virus coreceptor function of CXCR3 is strongly enhanced by mimicking the CXCR4 ligand binding pocket in the CXCR3 receptorSigrid Hatse, Dana Huskens, Katrien Princen, et al.
Antiviral Research|January 1, 2023
Design and synthesis of a new series of hybrids of functionalised N<sup>1</sup>-[(1H-1,2,3-triazol-4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial VirusIwona E Głowacka, Katarzyna Gawron, Dorota G Piotrowska, et al.
Plos Biology|December 3, 2014
Signal peptide-binding drug as a selective inhibitor of co-translational protein translocationKurt Vermeire, Thomas W Bell, Victor Van Puyenbroeck, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Molecular & Cellular Proteomics : MCP|September 5, 2021
A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor CyclotriazadisulfonamideEva Pauwels, Claudia Rutz, Becky Provinciael, et al.
Molecular Pharmacology|December 19, 2002
The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptorKurt Vermeire, Thomas W Bell, Heung-Jin Choi, et al.
Bioorganic & Medicinal Chemistry|November 12, 2020
Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compoundsLiezel A Lumangtad, Elisa Claeys, Sunil Hamal, et al.
Arthritis Research & Therapy|November 10, 2005
Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritisBert De Klerck, Lies Geboes, Sigrid Hatse, et al.
Microbiology Resource Announcements|May 18, 2019
Complete Genome Sequence of a New Ebola Virus Strain Isolated during the 2017 Likati Outbreak in the Democratic Republic of the CongoTony Wawina-Bokalanga, Bert Vanmechelen, Joan Martí-Carreras, et al.
European Journal of Medicinal Chemistry|January 30, 2025
The chiral 5,6-cyclohexane-fused uracil ring-system: A molecular platform with promising activity against SARS-CoV-2Enrico Marcantonio, Debora Guazzetti, Crescenzo Coppa, et al.
FEBS Letters|July 2, 2003
Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entrySigrid Hatse, Katrien Princen, Kurt Vermeire, et al.
Journal of Virology|January 26, 2007
Modest human immunodeficiency virus coreceptor function of CXCR3 is strongly enhanced by mimicking the CXCR4 ligand binding pocket in the CXCR3 receptorSigrid Hatse, Dana Huskens, Katrien Princen, et al.
Antiviral Research|January 1, 2023
Design and synthesis of a new series of hybrids of functionalised N<sup>1</sup>-[(1H-1,2,3-triazol-4-yl)methyl]quinazoline-2,4-dione with antiviral activity against Respiratory Syncytial VirusIwona E Głowacka, Katarzyna Gawron, Dorota G Piotrowska, et al.
Plos Biology|December 3, 2014
Signal peptide-binding drug as a selective inhibitor of co-translational protein translocationKurt Vermeire, Thomas W Bell, Victor Van Puyenbroeck, et al.
Pageof 9